SCA
ATRC icon

Snowden Capital Advisors’s AtriCure ATRC Stock Holding History

Snowden Capital Advisors’s Portfolio ATRC Stock Details ATRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-8,758
Closed -$266K – 1188
2024
Q1 		$266K Buy
8,758
+69
+0.8% +$2.31K 0.01% 1006
2023
Q4 		$310K Buy
8,689
+1,399
+19% +$52K 0.01% 894
2023
Q3 		$319K Sell
7,290
-124
-2% -$6.05K 0.01% 839
2023
Q2 		$366K Buy
7,414
+14
+0.2% +$645 0.01% 872
2023
Q1 		$307K Buy
7,400
+250
+3% +$10.4K 0.01% 931
2022
Q4 		$317K Buy
7,150
+551
+8% +$23K 0.01% 897
2022
Q3 		$258K Buy
+6,599
New +$302K 0.01% 948

Other funds holding ATRC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Snowden Capital Advisors's ATRC Position: Q2 2024 in Review

Snowden Capital Advisors sold out of AtriCure (ATRC) in Q2 2024, closing a stake of 8,758 shares — an estimated $266K sold.

Snowden Capital Advisors first reported a position in ATRC in Q3 2022 and held it in 7 quarters. The position peaked at $366K in Q2 2023. 197 funds tracked by Wall St. Rank hold ATRC as of Q2 2024.

  • Snowden Capital Advisors reported no remaining AtriCure position as of Q2 2024 after selling out during the quarter.
  • Snowden Capital Advisors sold 8,758 AtriCure shares in Q2 2024, an estimated $266K.
  • Snowden Capital Advisors first reported a position in AtriCure in Q3 2022 and held it in 7 quarters.
  • Snowden Capital Advisors's AtriCure position peaked at $366K in Q2 2023.
  • 197 funds tracked by Wall St. Rank held AtriCure as of Q2 2024.

Based on Snowden Capital Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.